JP2016526535A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526535A5
JP2016526535A5 JP2016519625A JP2016519625A JP2016526535A5 JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5 JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5
Authority
JP
Japan
Prior art keywords
difluoro
substituted
ethynyl
tetrazol
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016519625A
Other languages
English (en)
Japanese (ja)
Other versions
JP6386035B2 (ja
JP2016526535A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/041984 external-priority patent/WO2014201161A1/en
Publication of JP2016526535A publication Critical patent/JP2016526535A/ja
Publication of JP2016526535A5 publication Critical patent/JP2016526535A5/ja
Application granted granted Critical
Publication of JP6386035B2 publication Critical patent/JP6386035B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016519625A 2013-06-12 2014-06-11 金属酵素阻害剤化合物 Expired - Fee Related JP6386035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361834324P 2013-06-12 2013-06-12
US61/834,324 2013-06-12
PCT/US2014/041984 WO2014201161A1 (en) 2013-06-12 2014-06-11 Metalloenzyme inhibitor compounds

Publications (3)

Publication Number Publication Date
JP2016526535A JP2016526535A (ja) 2016-09-05
JP2016526535A5 true JP2016526535A5 (enExample) 2017-06-22
JP6386035B2 JP6386035B2 (ja) 2018-09-05

Family

ID=52022749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519625A Expired - Fee Related JP6386035B2 (ja) 2013-06-12 2014-06-11 金属酵素阻害剤化合物

Country Status (9)

Country Link
US (1) US9688671B2 (enExample)
EP (1) EP3008051A4 (enExample)
JP (1) JP6386035B2 (enExample)
KR (1) KR20160018811A (enExample)
CN (1) CN105431418B (enExample)
AU (1) AU2014278172B2 (enExample)
CA (1) CA2915054A1 (enExample)
EA (1) EA201690007A1 (enExample)
WO (1) WO2014201161A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014MN01378A (enExample) 2011-12-11 2015-07-03 Viamet Pharmaceuticals Inc
WO2013109998A1 (en) * 2012-01-20 2013-07-25 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
AU2015231275B2 (en) 2014-03-19 2019-03-07 Mycovia Pharmaceuticals, Inc. Antifungal compound process
EP3119753B1 (en) 2014-03-19 2020-11-04 Dow AgroSciences LLC 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
CN109970629B (zh) 2014-03-19 2023-04-11 迈科维亚医药公司 抗真菌化合物的制备方法
KR102441243B1 (ko) 2014-03-19 2022-09-07 브이피에스-3, 엘엘씨 2-(2,4-디플루오르페닐)-1,1-디플루오르-1-(5-치환된-피리딘-2-일)-3-(1h-테트라졸-1-일)프로판-2-올 및 이의 제조방법
WO2015143184A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
AU2015231216B2 (en) 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP2017509646A (ja) 2014-03-19 2017-04-06 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
CA2942936A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
JP6606508B2 (ja) 2014-03-19 2019-11-13 マイコヴィア ファーマシューティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
MA40940A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
CN107108613B (zh) 2014-11-10 2020-02-25 基因泰克公司 布罗莫结构域抑制剂及其用途
MA40943A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
EP3250571B1 (en) * 2015-01-29 2022-11-30 Genentech, Inc. Therapeutic compounds and uses thereof
CN108289457B (zh) 2015-09-18 2021-08-06 迈科维亚医药公司 抗真菌化合物制备方法
EA038421B1 (ru) 2015-12-30 2021-08-26 ВиПиЭс-3, ИНК. Соединения, ингибирующие металлоферменты
AU2019229978B2 (en) 2018-03-05 2024-05-30 Arcus Biosciences, Inc. Arginase inhibitors
CA3117599A1 (en) * 2018-10-29 2020-05-07 Huahai Us Inc. Novel dipeptide compounds and uses thereof
TWI828800B (zh) 2018-11-16 2024-01-11 美商阿克思生物科學有限公司 Arg1及/或arg2之抑制劑
WO2020263191A1 (en) 2019-06-27 2020-12-30 Nanyang Technological University Compounds having antimalarial activity
CN110885323A (zh) * 2019-12-02 2020-03-17 中国人民解放军第二军医大学 一种三氮唑醇类衍生物、其制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080062876A (ko) 2006-12-29 2008-07-03 주식회사 대웅제약 신규한 항진균성 트리아졸 유도체
AU2011242562B2 (en) * 2010-04-24 2016-10-13 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
AU2012273100B2 (en) 2011-06-19 2017-05-25 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
KR20140040235A (ko) * 2011-06-19 2014-04-02 비아멧 파마슈티컬즈, 인코포레이티드 금속효소 억제제 화합물
US8940735B2 (en) * 2011-06-23 2015-01-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
IN2014MN01378A (enExample) * 2011-12-11 2015-07-03 Viamet Pharmaceuticals Inc

Similar Documents

Publication Publication Date Title
JP2016526535A5 (enExample)
JP6386035B2 (ja) 金属酵素阻害剤化合物
US11247981B2 (en) Metalloenzyme inhibitor compounds
AU2011242562B2 (en) Metalloenzyme inhibitor compounds
US10919874B2 (en) Metalloenzyme inhibitor compounds